Raymond James & Associates’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
BCM
CCM
FAM
TAM
Raymond James & Associates's CYRX Position: Q3 2024 in Review
Raymond James & Associates sold out of CryoPort (CYRX) in Q3 2024, closing a stake of 16,428 shares — an estimated $114K sold.
Raymond James & Associates first reported a position in CYRX in Q3 2020 and held it in 16 quarters. The position peaked at $2.26M in Q2 2021. 152 funds tracked by Wall St. Rank hold CYRX as of Q3 2024.
- Raymond James & Associates reported no remaining CryoPort position as of Q3 2024 after selling out during the quarter.
- Raymond James & Associates sold 16,428 CryoPort shares in Q3 2024, an estimated $114K.
- Raymond James & Associates first reported a position in CryoPort in Q3 2020 and held it in 16 quarters.
- Raymond James & Associates's CryoPort position peaked at $2.26M in Q2 2021.
- 152 funds tracked by Wall St. Rank held CryoPort as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.